| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Habenula | 13 | 2021 | 45 | 5.270 |
Why?
|
| Receptors, Nicotinic | 18 | 2023 | 205 | 3.810 |
Why?
|
| Depressive Disorder, Major | 10 | 2023 | 436 | 3.200 |
Why?
|
| Connectome | 7 | 2021 | 113 | 2.590 |
Why?
|
| Suicidal Ideation | 7 | 2024 | 211 | 2.210 |
Why?
|
| Cerebral Cortex | 7 | 2021 | 631 | 2.210 |
Why?
|
| Substance Withdrawal Syndrome | 8 | 2020 | 256 | 2.090 |
Why?
|
| Nicotine | 14 | 2019 | 265 | 1.950 |
Why?
|
| Suicide, Attempted | 4 | 2024 | 130 | 1.870 |
Why?
|
| Brain | 16 | 2024 | 4213 | 1.860 |
Why?
|
| Bipolar Disorder | 4 | 2023 | 358 | 1.760 |
Why?
|
| Magnetic Resonance Imaging | 31 | 2024 | 7895 | 1.650 |
Why?
|
| Substance-Related Disorders | 5 | 2024 | 547 | 1.600 |
Why?
|
| Smoking | 10 | 2021 | 2555 | 1.460 |
Why?
|
| Gyrus Cinguli | 3 | 2023 | 127 | 1.340 |
Why?
|
| Tobacco Use Disorder | 6 | 2021 | 300 | 1.240 |
Why?
|
| Suicide | 5 | 2024 | 189 | 1.240 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2018 | 292 | 1.150 |
Why?
|
| Mental Disorders | 7 | 2020 | 882 | 1.130 |
Why?
|
| Temporal Lobe | 2 | 2020 | 191 | 1.100 |
Why?
|
| Neuroimaging | 6 | 2023 | 402 | 1.070 |
Why?
|
| Hippocampus | 7 | 2020 | 973 | 1.040 |
Why?
|
| Prefrontal Cortex | 5 | 2020 | 216 | 1.040 |
Why?
|
| Amnesia | 2 | 2024 | 23 | 1.020 |
Why?
|
| White Matter | 3 | 2016 | 188 | 0.960 |
Why?
|
| Brain Mapping | 8 | 2024 | 625 | 0.960 |
Why?
|
| Nerve Net | 2 | 2019 | 274 | 0.930 |
Why?
|
| Parietal Lobe | 1 | 2024 | 68 | 0.900 |
Why?
|
| Behavior, Animal | 7 | 2017 | 750 | 0.880 |
Why?
|
| Nicotinic Agonists | 5 | 2019 | 120 | 0.850 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 168 | 0.850 |
Why?
|
| Amygdala | 3 | 2018 | 114 | 0.820 |
Why?
|
| Rest | 3 | 2019 | 69 | 0.820 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2020 | 643 | 0.800 |
Why?
|
| Nerve Tissue Proteins | 5 | 2017 | 1582 | 0.770 |
Why?
|
| Neural Pathways | 3 | 2024 | 313 | 0.760 |
Why?
|
| Cerebellum | 2 | 2024 | 471 | 0.750 |
Why?
|
| Inpatients | 7 | 2024 | 686 | 0.740 |
Why?
|
| Electronic Nicotine Delivery Systems | 3 | 2019 | 74 | 0.710 |
Why?
|
| Protein Subunits | 9 | 2009 | 279 | 0.690 |
Why?
|
| Reward | 6 | 2024 | 176 | 0.690 |
Why?
|
| Depression | 5 | 2023 | 1733 | 0.680 |
Why?
|
| Anorexia Nervosa | 1 | 2019 | 30 | 0.680 |
Why?
|
| Anxiety | 8 | 2023 | 1236 | 0.660 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 327 | 0.650 |
Why?
|
| Patient Discharge | 1 | 2024 | 700 | 0.640 |
Why?
|
| Personality Disorders | 1 | 2020 | 165 | 0.600 |
Why?
|
| Corpus Striatum | 4 | 2017 | 105 | 0.580 |
Why?
|
| Head Movements | 1 | 2016 | 26 | 0.530 |
Why?
|
| Feedback, Psychological | 1 | 2016 | 20 | 0.530 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2015 | 19 | 0.520 |
Why?
|
| Olfactory Cortex | 1 | 2015 | 3 | 0.500 |
Why?
|
| Data Mining | 1 | 2015 | 83 | 0.490 |
Why?
|
| Hallucinations | 1 | 2015 | 34 | 0.490 |
Why?
|
| Functional Laterality | 2 | 2017 | 277 | 0.480 |
Why?
|
| Humans | 65 | 2024 | 270802 | 0.470 |
Why?
|
| Male | 47 | 2024 | 128397 | 0.460 |
Why?
|
| Adult | 33 | 2024 | 81997 | 0.460 |
Why?
|
| Drama | 1 | 2013 | 13 | 0.460 |
Why?
|
| Female | 48 | 2024 | 148967 | 0.450 |
Why?
|
| Weight Loss | 1 | 2018 | 629 | 0.450 |
Why?
|
| Young Adult | 15 | 2024 | 22225 | 0.410 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 416 | 0.410 |
Why?
|
| Impulsive Behavior | 3 | 2023 | 151 | 0.400 |
Why?
|
| Antidepressive Agents | 4 | 2021 | 335 | 0.400 |
Why?
|
| Receptors, GABA-A | 4 | 2008 | 83 | 0.400 |
Why?
|
| Teaching | 1 | 2013 | 251 | 0.390 |
Why?
|
| Pilot Projects | 5 | 2023 | 2848 | 0.360 |
Why?
|
| Social Behavior | 1 | 2012 | 310 | 0.360 |
Why?
|
| Autism Spectrum Disorder | 1 | 2015 | 375 | 0.350 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 980 | 0.350 |
Why?
|
| Ketamine | 3 | 2021 | 241 | 0.340 |
Why?
|
| Tegmentum Mesencephali | 1 | 2009 | 3 | 0.330 |
Why?
|
| Education, Medical | 1 | 2013 | 344 | 0.330 |
Why?
|
| Locus Coeruleus | 2 | 2019 | 32 | 0.330 |
Why?
|
| Organ Size | 3 | 2021 | 692 | 0.330 |
Why?
|
| Nucleus Accumbens | 2 | 2020 | 63 | 0.320 |
Why?
|
| Thalamus | 2 | 2020 | 123 | 0.320 |
Why?
|
| Acetylcholinesterase | 1 | 2008 | 27 | 0.320 |
Why?
|
| Case-Control Studies | 5 | 2020 | 6237 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 14 | 2019 | 7103 | 0.300 |
Why?
|
| Communication | 1 | 2013 | 839 | 0.290 |
Why?
|
| Drug Tolerance | 1 | 2007 | 123 | 0.290 |
Why?
|
| Locomotion | 2 | 2004 | 87 | 0.280 |
Why?
|
| Stress, Physiological | 2 | 2008 | 493 | 0.280 |
Why?
|
| Dopaminergic Neurons | 2 | 2018 | 53 | 0.280 |
Why?
|
| Craving | 2 | 2019 | 43 | 0.280 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 2 | 2021 | 106 | 0.270 |
Why?
|
| Mice | 24 | 2019 | 35597 | 0.270 |
Why?
|
| Anesthetics, Local | 1 | 2007 | 179 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 1233 | 0.260 |
Why?
|
| Mood Disorders | 2 | 2023 | 163 | 0.260 |
Why?
|
| Seizures | 4 | 2004 | 1036 | 0.260 |
Why?
|
| Cocaine | 1 | 2007 | 242 | 0.260 |
Why?
|
| Mice, Knockout | 9 | 2012 | 5731 | 0.250 |
Why?
|
| Anxiety Disorders | 2 | 2021 | 725 | 0.240 |
Why?
|
| Homeostasis | 3 | 2019 | 926 | 0.240 |
Why?
|
| Maze Learning | 4 | 2017 | 142 | 0.240 |
Why?
|
| Cell Membrane | 4 | 2008 | 878 | 0.230 |
Why?
|
| Middle Aged | 17 | 2024 | 90347 | 0.220 |
Why?
|
| Comorbidity | 2 | 2020 | 2392 | 0.220 |
Why?
|
| Animals | 27 | 2019 | 62048 | 0.220 |
Why?
|
| Phobia, Social | 1 | 2023 | 5 | 0.220 |
Why?
|
| Receptor Aggregation | 2 | 2006 | 15 | 0.220 |
Why?
|
| Personality | 1 | 2024 | 124 | 0.210 |
Why?
|
| Mice, Mutant Strains | 4 | 2009 | 655 | 0.210 |
Why?
|
| Aftercare | 1 | 2024 | 252 | 0.200 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 2351 | 0.200 |
Why?
|
| Smoking Cessation | 3 | 2021 | 776 | 0.190 |
Why?
|
| Membrane Transport Modulators | 1 | 2021 | 9 | 0.190 |
Why?
|
| Cachexia | 1 | 2023 | 165 | 0.190 |
Why?
|
| Dopamine | 3 | 2008 | 333 | 0.190 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2021 | 19 | 0.190 |
Why?
|
| Phenylenediamines | 1 | 2021 | 22 | 0.190 |
Why?
|
| Anhedonia | 1 | 2021 | 35 | 0.190 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2021 | 35 | 0.190 |
Why?
|
| Ventral Striatum | 1 | 2021 | 35 | 0.190 |
Why?
|
| Carbamates | 1 | 2021 | 81 | 0.180 |
Why?
|
| Adolescent | 9 | 2023 | 32743 | 0.180 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 5171 | 0.170 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 680 | 0.170 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 1145 | 0.170 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 273 | 0.170 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 5 | 2007 | 59 | 0.160 |
Why?
|
| Carbon Monoxide | 1 | 2019 | 68 | 0.160 |
Why?
|
| Hospitals, Psychiatric | 1 | 2019 | 72 | 0.160 |
Why?
|
| Vaping | 1 | 2019 | 42 | 0.160 |
Why?
|
| Nicotinic Antagonists | 2 | 2009 | 17 | 0.160 |
Why?
|
| Raphe Nuclei | 1 | 2018 | 36 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 558 | 0.160 |
Why?
|
| Analysis of Variance | 3 | 2008 | 2320 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 1 | 2020 | 483 | 0.150 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 102 | 0.150 |
Why?
|
| Neurons | 4 | 2015 | 2454 | 0.150 |
Why?
|
| Ganglionic Stimulants | 2 | 2011 | 16 | 0.150 |
Why?
|
| Caudate Nucleus | 1 | 2017 | 42 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2015 | 1689 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2017 | 907 | 0.150 |
Why?
|
| Spatial Memory | 1 | 2017 | 41 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2024 | 4134 | 0.140 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 4 | 2008 | 1013 | 0.140 |
Why?
|
| Genotype | 3 | 2020 | 4255 | 0.140 |
Why?
|
| Avoidance Learning | 1 | 2017 | 95 | 0.140 |
Why?
|
| Frontal Lobe | 1 | 2017 | 167 | 0.140 |
Why?
|
| Faith Healing | 1 | 2016 | 3 | 0.140 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 106 | 0.140 |
Why?
|
| Mecamylamine | 2 | 2007 | 15 | 0.140 |
Why?
|
| Pyridines | 4 | 2008 | 1311 | 0.140 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 419 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 242 | 0.130 |
Why?
|
| Encephalitis | 1 | 2017 | 153 | 0.130 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2016 | 13 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 2618 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 476 | 0.130 |
Why?
|
| Ventral Tegmental Area | 1 | 2016 | 51 | 0.130 |
Why?
|
| Neoplasms | 2 | 2023 | 15919 | 0.130 |
Why?
|
| Anisotropy | 1 | 2016 | 181 | 0.130 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2016 | 95 | 0.130 |
Why?
|
| Machine Learning | 1 | 2019 | 363 | 0.130 |
Why?
|
| Neuroglia | 1 | 2017 | 252 | 0.130 |
Why?
|
| Cytoplasm | 2 | 2008 | 701 | 0.130 |
Why?
|
| Brain Concussion | 1 | 2017 | 214 | 0.120 |
Why?
|
| Virtual Reality Exposure Therapy | 1 | 2014 | 6 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2019 | 700 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2017 | 288 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 4375 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2019 | 799 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 514 | 0.120 |
Why?
|
| Culture | 1 | 2015 | 104 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 4963 | 0.120 |
Why?
|
| Corpus Callosum | 1 | 2014 | 127 | 0.120 |
Why?
|
| Risk Factors | 2 | 2024 | 17900 | 0.110 |
Why?
|
| Schizophrenia | 1 | 2016 | 317 | 0.110 |
Why?
|
| Pregnant Women | 1 | 2014 | 158 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 5002 | 0.100 |
Why?
|
| Motor Activity | 3 | 2017 | 712 | 0.100 |
Why?
|
| Psychiatry | 1 | 2016 | 276 | 0.100 |
Why?
|
| Aged | 5 | 2024 | 73382 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 809 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 1028 | 0.100 |
Why?
|
| Synapses | 1 | 2016 | 556 | 0.100 |
Why?
|
| Smell | 1 | 2012 | 134 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2004 | 5440 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 2222 | 0.090 |
Why?
|
| Logistic Models | 1 | 2018 | 3448 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2008 | 4223 | 0.090 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2011 | 103 | 0.090 |
Why?
|
| Oxygen | 1 | 2015 | 792 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2013 | 636 | 0.090 |
Why?
|
| Biomarkers | 2 | 2019 | 5060 | 0.090 |
Why?
|
| Estrous Cycle | 1 | 2009 | 40 | 0.080 |
Why?
|
| Emotions | 3 | 2017 | 560 | 0.080 |
Why?
|
| Radioligand Assay | 1 | 2008 | 57 | 0.080 |
Why?
|
| Memory | 1 | 2012 | 445 | 0.080 |
Why?
|
| Eating | 1 | 2011 | 448 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2008 | 1710 | 0.080 |
Why?
|
| Iodine Isotopes | 1 | 2008 | 11 | 0.080 |
Why?
|
| Heart Rate | 2 | 2020 | 751 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1568 | 0.080 |
Why?
|
| Double-Blind Method | 3 | 2021 | 2588 | 0.080 |
Why?
|
| COS Cells | 3 | 2006 | 417 | 0.080 |
Why?
|
| Lung | 1 | 2019 | 3300 | 0.080 |
Why?
|
| Mesencephalon | 1 | 2008 | 58 | 0.080 |
Why?
|
| Veterans | 1 | 2020 | 1740 | 0.080 |
Why?
|
| Aconitine | 1 | 2007 | 11 | 0.070 |
Why?
|
| Quality of Life | 2 | 2023 | 4775 | 0.070 |
Why?
|
| Precision Medicine | 1 | 2016 | 1208 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 4831 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 191 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2008 | 6398 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2007 | 103 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 3604 | 0.070 |
Why?
|
| Sex Factors | 2 | 2019 | 2184 | 0.070 |
Why?
|
| Rats | 2 | 2008 | 6525 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 651 | 0.070 |
Why?
|
| Progesterone | 1 | 2009 | 711 | 0.070 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 2 | 2004 | 36 | 0.060 |
Why?
|
| Grooming | 1 | 2004 | 10 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2004 | 97 | 0.060 |
Why?
|
| Mastication | 1 | 2004 | 20 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2008 | 286 | 0.060 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 65 | 0.060 |
Why?
|
| Protein Binding | 2 | 2008 | 3485 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 121 | 0.060 |
Why?
|
| Age Factors | 1 | 2014 | 5465 | 0.060 |
Why?
|
| Serotonin | 1 | 2005 | 287 | 0.060 |
Why?
|
| Densitometry | 1 | 2003 | 51 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5778 | 0.060 |
Why?
|
| Protein Transport | 2 | 2006 | 737 | 0.060 |
Why?
|
| Telemetry | 1 | 2003 | 40 | 0.060 |
Why?
|
| Spatial Behavior | 1 | 2003 | 20 | 0.060 |
Why?
|
| Transfection | 3 | 2006 | 3118 | 0.060 |
Why?
|
| Tremor | 1 | 2004 | 133 | 0.050 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2003 | 71 | 0.050 |
Why?
|
| Social Isolation | 1 | 2003 | 58 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 338 | 0.050 |
Why?
|
| Cell Movement | 2 | 2008 | 2472 | 0.050 |
Why?
|
| Texas | 1 | 2013 | 6447 | 0.050 |
Why?
|
| Phenotype | 2 | 2012 | 6516 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 5071 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2004 | 345 | 0.050 |
Why?
|
| Hyperalgesia | 1 | 2004 | 244 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 1050 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 2474 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2008 | 2422 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 7383 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2004 | 1685 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2018 | 33741 | 0.050 |
Why?
|
| COUP Transcription Factor I | 1 | 2002 | 93 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2001 | 54 | 0.050 |
Why?
|
| Child | 3 | 2021 | 30546 | 0.050 |
Why?
|
| Cell Line | 3 | 2008 | 5339 | 0.050 |
Why?
|
| Response Elements | 1 | 2002 | 192 | 0.050 |
Why?
|
| Functional Neuroimaging | 1 | 2021 | 36 | 0.050 |
Why?
|
| Cause of Death | 1 | 2024 | 788 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 2001 | 160 | 0.050 |
Why?
|
| Pregnancy | 1 | 2014 | 8125 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 904 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2021 | 248 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2001 | 295 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 632 | 0.040 |
Why?
|
| Mental Health | 1 | 2023 | 415 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2001 | 328 | 0.040 |
Why?
|
| Membrane Potentials | 3 | 2008 | 444 | 0.040 |
Why?
|
| Solvents | 1 | 2019 | 67 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 71 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2019 | 14 | 0.040 |
Why?
|
| Smoke | 1 | 2019 | 61 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 239 | 0.040 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2019 | 42 | 0.040 |
Why?
|
| Gene Expression | 2 | 2004 | 3642 | 0.040 |
Why?
|
| Wakefulness | 1 | 2020 | 157 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 1558 | 0.040 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2019 | 53 | 0.040 |
Why?
|
| Phospholipids | 1 | 2019 | 167 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 2009 | 5698 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 747 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2001 | 477 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2019 | 212 | 0.040 |
Why?
|
| Body Weight | 1 | 2023 | 1311 | 0.040 |
Why?
|
| Gliosis | 1 | 2017 | 44 | 0.040 |
Why?
|
| Defense Mechanisms | 1 | 2017 | 19 | 0.040 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 159 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1111 | 0.040 |
Why?
|
| Binding Sites | 1 | 2002 | 2256 | 0.040 |
Why?
|
| Fluorescence | 2 | 2008 | 198 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 30 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2021 | 565 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2017 | 161 | 0.030 |
Why?
|
| Sleep | 1 | 2020 | 446 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 906 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2004 | 2165 | 0.030 |
Why?
|
| Microglia | 1 | 2017 | 181 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 1642 | 0.030 |
Why?
|
| Religion | 1 | 2016 | 95 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2017 | 237 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 3028 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 1292 | 0.030 |
Why?
|
| Base Sequence | 1 | 2002 | 5437 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1960 | 0.030 |
Why?
|
| Models, Animal | 1 | 2017 | 657 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2017 | 335 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 1164 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 5923 | 0.030 |
Why?
|
| Self-Assessment | 1 | 2014 | 89 | 0.030 |
Why?
|
| Time Factors | 1 | 2008 | 13021 | 0.030 |
Why?
|
| Tobacco Products | 1 | 2016 | 154 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 3215 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 6686 | 0.030 |
Why?
|
| Astrocytes | 1 | 2017 | 405 | 0.030 |
Why?
|
| Visual Perception | 1 | 2015 | 150 | 0.030 |
Why?
|
| Placebos | 1 | 2015 | 443 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2014 | 271 | 0.030 |
Why?
|
| Cues | 1 | 2014 | 203 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2015 | 207 | 0.030 |
Why?
|
| United States | 2 | 2024 | 15855 | 0.030 |
Why?
|
| Attention | 1 | 2015 | 286 | 0.030 |
Why?
|
| Self Report | 1 | 2017 | 797 | 0.030 |
Why?
|
| Exercise | 1 | 2020 | 1207 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 5149 | 0.020 |
Why?
|
| Azocines | 1 | 2011 | 3 | 0.020 |
Why?
|
| Quinolizines | 1 | 2011 | 11 | 0.020 |
Why?
|
| Melanocortins | 1 | 2011 | 13 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 2057 | 0.020 |
Why?
|
| Amino Acid Substitution | 2 | 2004 | 657 | 0.020 |
Why?
|
| Alkaloids | 1 | 2011 | 85 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2024 | 2886 | 0.020 |
Why?
|
| Diestrus | 1 | 2009 | 3 | 0.020 |
Why?
|
| Hindlimb Suspension | 1 | 2009 | 16 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 4877 | 0.020 |
Why?
|
| Corticosterone | 1 | 2009 | 123 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2009 | 94 | 0.020 |
Why?
|
| Pituitary-Adrenal System | 1 | 2009 | 97 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2009 | 127 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2008 | 133 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 4943 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 300 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 398 | 0.020 |
Why?
|
| Photobleaching | 1 | 2006 | 5 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2008 | 492 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 4498 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2009 | 272 | 0.020 |
Why?
|
| Fluoxetine | 1 | 2005 | 46 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2005 | 46 | 0.020 |
Why?
|
| COUP Transcription Factors | 1 | 2004 | 46 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 31008 | 0.010 |
Why?
|
| Codon | 1 | 2004 | 261 | 0.010 |
Why?
|
| Boron Compounds | 1 | 2004 | 69 | 0.010 |
Why?
|
| COUP Transcription Factor II | 1 | 2004 | 120 | 0.010 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 246 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 590 | 0.010 |
Why?
|
| Conotoxins | 1 | 2002 | 3 | 0.010 |
Why?
|
| Lipotropic Agents | 1 | 2002 | 7 | 0.010 |
Why?
|
| Muscle Denervation | 1 | 2002 | 11 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 15911 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 938 | 0.010 |
Why?
|
| Choline | 1 | 2002 | 73 | 0.010 |
Why?
|
| Dihydro-beta-Erythroidine | 1 | 2002 | 4 | 0.010 |
Why?
|
| Neuroanatomy | 1 | 2002 | 11 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 17048 | 0.010 |
Why?
|
| Bungarotoxins | 1 | 2002 | 19 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 1496 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 469 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 209 | 0.010 |
Why?
|
| Threonine | 1 | 2002 | 163 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2002 | 361 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 1095 | 0.010 |
Why?
|
| Lysine | 1 | 2002 | 426 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 12102 | 0.010 |
Why?
|
| Ligands | 1 | 2002 | 1016 | 0.010 |
Why?
|
| Heterozygote | 1 | 2002 | 1056 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 3478 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7665 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 4645 | 0.010 |
Why?
|